Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10426837 Compositions and methods for treating CNS disorders

Patent 10426837 was granted and assigned to SAGE Therapeutics on October, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

104268370

Patent Inventor Names

Boyd L. Harrison0

Francesco G. Salituro0

Gabriel Martinez Botella0

Albert J. Robichaud0

Date of Patent

October 1, 2019

Patent Application Number

156601140

Date Filed

July 26, 2017

Patent Citations

‌

US Patent 10246482 Neuroactive steroids, compositions, and uses thereof

Patent Citations Received

‌

US Patent 11945836 Compositions and methods for treating CNS disorders

‌

US Patent 12083131 Neuroactive steroids, compositions, and uses thereof

‌

US Patent 12060386 Compositions and methods for treating CNS disorders

Patent Primary Examiner

‌

Barbara P Badio

Patent abstract

Described herein are neuroactive steroids of the Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10426837 Compositions and methods for treating CNS disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API